Denali Therapeutics

Ultragenyx Pharmaceutical

TAKEDA PHARMACEUTICAL CO

Denali's DNL126 achieves 80% CSF heparan sulfate reduction in Sanfilippo trial, setting up potential 2027 approval as tividenofusp alfa awaits April FDA decision.

Denali Posts Best-in-Class Sanfilippo Data at WORLD Symposium, Eyes Back-to-Back Rare Disease Approvals

Bob's Discount Furniture

Wayfair

WILLIAMS SONOMA

Arhaus

Bob's Discount Furniture raises $331M in NYSE debut at $2.2B valuation. Bain Capital's 12-year bet tests the PE retail exit window.

Bob's Discount Furniture Lands $2.2B Valuation in NYSE Debut, Testing PE Exit Window

MOLINA HEALTHCARE

UNITEDHEALTH GROUP

Elevance Health

CENTENE

HUMANA

CVS HEALTH

Molina Healthcare stock crashes 33% after guiding 2026 EPS to $5.00 vs. $13.71 consensus—a 63% miss—and announces exit from Medicare Advantage Part D.

Molina Healthcare Crashes 33% on 63% EPS Guidance Miss, Exits Medicare Advantage Part D

CIENA

VISA

Dayforce

Meta Platforms

AT&T

Ciena rejoins S&P 500 after 17-year absence, replacing Dayforce. Stock up 197% as AI demand drives record orders and 24% revenue growth guidance.

Ciena Rejoins S&P 500 After 17 Years as AI Demand Transforms the Dot-Com Survivor

ZenaTech

AeroVironment

KRATOS DEFENSE & SECURITY SOLUTIONS

Red Cat Holdings

ZenaTech CFO presents 1,225% revenue growth at Noble conference, but shares fall 11% to $2.67—70% below IPO. Inside the DaaS roll-up story.

ZenaTech Touts 1,225% Revenue Surge at Noble Conference as Stock Slides 70% From IPO

BUCKLE

Buckle reports FY2026 sales of $1.298B, up 6.6%. Women's apparel surges 6.5% while men's slips 2.5%. January comps slow to +1.7%.

Buckle Closes Fiscal 2026 With $1.3B in Sales as Women's Apparel Drives Growth

News